跳至主要内容
临床试验/ACTRN12620000382976
ACTRN12620000382976已完成未知

A follow-up of the Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP) and their children: REVAMP Extend

niversity of Malawi, College of Medicine0 个研究点目标入组 862 人开始时间: 2020年3月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
862

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
3 Months 至 o limit(—)
性别
All

入选标准

  • Participants must have participated in the main REVAMP trial, or be a child born to a participant of the parent study to be included in this substudy.
  • Participants meeting the following criteria were included in the parent trial (main REVAMP trial):
  • 1.Confirmed singleton pregnancy at 13-26 weeks gestation
  • 2.Moderate to severe anaemia not requiring an immediate blood transfusion (Hb <10g/dl)
  • 3.Negative malaria parasitaemia
  • 4.Resident in the study catchment area of Blantyre and Zomba district
  • 5.Plan to deliver at a health facility
  • 6.Written informed consent (including assent if <18 years old)

排除标准

  • Non participation in the main REVAMP trial.

研究者

发起方
niversity of Malawi, College of Medicine

相似试验